Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare
Crispr Therapeutics AG Shares Outstanding 2015–2025
Crispr Therapeutics AG annual/quarterly shares outstanding history and growth rate from 2015 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Crispr Therapeutics AG shares outstanding for the quarter ending March 31, 2026 was 0.10 B shs, a 11.77% increase year-over-year.
- Crispr Therapeutics AG annual shares outstanding for 2025 was 0.09 B shs, a 6.60% increase from 2024.
- Crispr Therapeutics AG annual shares outstanding for 2024 was 0.08 B shs, a 6.49% increase from 2023.
- Crispr Therapeutics AG annual shares outstanding for 2023 was 0.08 B shs, a 1.90% increase from 2022.
- Crispr Therapeutics AG annual shares outstanding for 2022 was 0.08 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Crispr Therapeutics AG Shares Outstanding — FAQ
Crispr Therapeutics AG (CRSP) shares outstanding over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Crispr Therapeutics AG's shares outstanding?
Crispr Therapeutics AG (CRSP) reported shares outstanding of 0.09B shares for fiscal 2025.
Where can I see CRSP's shares outstanding history?
The chart and table above show Crispr Therapeutics AG's shares outstanding by year and by quarter, including the growth rate.